San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, BioQ Pharma is raising $18,750,000.00 in new funding. Sources indicate as part of senior management President, Joshua Kriesel played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About BioQ Pharma

BioQ Pharma has proprietary development, regulatory and manufacturing know-how to implement solutions for a wide range of infusible pharmaceuticals. We have the ability to provide a safe, proven and more efficient alternative to reformulation of infusibles. Our vision to set a new standard of care for infusions is enabled by our invenious platform a technology built to address some of the most pressing unmet needs in infusion today: cost, medication error, sterility, efficiency, and patient quality of life.

To learn more about BioQ Pharma, visit http://www.bioqpharma.com/

Contact:
Joshua Kriesel, President
415-975-0805
https://www.linkedin.com/in/joshua-kriesel-a0a86014/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved